FDA.reportPublic FDA data

phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]

RxCUI
2677798
RxNorm name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Display name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Full name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RyzumviPHENTOLAMINE MESYLATEOyster Point Pharma, Inc.96bb1e53-c2cc-4e60-a21a-db0269c371bf2026-03-15Warnings, Adverse reactionsExact identifier
rxcui: 2677798

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
96bb1e53-c2cc-4e60-a21a-db0269c371bfphentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]SBD4These highlights do not include all the information needed to use RYZUMVI safely and effectively. See full prescribing information for RYZUMVI. RYZUMVI™ (phentolamine ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 195220240531
96bb1e53-c2cc-4e60-a21a-db0269c371bfRyzumvi 7.5 MG (as phentolamine mesylate 10 MG) per 1 ML Ophthalmic SolutionSY4These highlights do not include all the information needed to use RYZUMVI safely and effectively. See full prescribing information for RYZUMVI. RYZUMVI™ (phentolamine ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 195220240531
96bb1e53-c2cc-4e60-a21a-db0269c371bfRyzumvi 0.75 % Ophthalmic SolutionPSN4These highlights do not include all the information needed to use RYZUMVI safely and effectively. See full prescribing information for RYZUMVI. RYZUMVI™ (phentolamine ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 195220240531